Peter T. Ender
- Endocrinology top 5%
- Escherichia coli research studies 2
- Vibrio bacteria research studies 1
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 3
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 2
- Viral gastroenteritis research and epidemiology 1
- SARS-CoV-2 and COVID-19 Research 1
- Parasitology top 10%
-
- Injury Epidemiology and Prevention 2
-
- Salmonella and Campylobacter epidemiology 1
- Co-authors
- Matthew J. DolanBrian JohnstonJames R. JohnsonConnie ClabotsSteven J. DurningLannie J. CationDavid P. DooleyDeepakraj Gajanana
- Journals
- Clinical Infectious Diseases (3 papers)Open Forum Infectious Diseases (3 papers)Journal of Emergency Medicine (1 paper)
- Partner nations
- United States
In The Last Decade
Peter T. Ender
18 papers receiving 471 citations
Peers
Comparison fields: 5 of 79
- Endocrinology 136
- Molecular Medicine 104
- Infectious Diseases 151
- Parasitology 32
- Emergency Medicine 42
Countries citing papers authored by Peter T. Ender
This map shows the geographic impact of Peter T. Ender's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter T. Ender with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter T. Ender more than expected).
Fields of papers citing papers by Peter T. Ender
This network shows the impact of papers produced by Peter T. Ender. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter T. Ender. The network helps show where Peter T. Ender may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter T. Ender, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2021 | 10 | |
| 3 | 2020 | 3 | |
| 4 | 2016 | 53 | |
| 5 | 2015 | 15 | |
| 6 | 2013 | 22 | |
| 7 | 2012 | 2 | |
| 8 | 2009 | 53 | |
| 9 | 2004 | 41 | |
| 10 | Cytomegalovirus colitis in an immunocompetent patient with amebiasis: case report and review of the literature. | 2004 | 12 |
| 11 | 2003 | 2 | |
| 12 | 2002 | 46 | |
| 13 | 2001 | 4 | |
| 14 | 2001 | 61 | |
| 15 | 2001 | 2 | |
| 16 | 1999 | 7 | |
| 17 | 1997 | 107 | |
| 18 | 1996 | 37 | |
| 19 | 1996 | 28 |
About Peter T. Ender
Peter T. Ender is a scholar working on Leadership and Management, Endocrinology, Molecular Medicine, Applied Microbiology and Biotechnology and Parasitology, having authored 19 papers that have together received 505 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (3 papers), COVID-19 Clinical Research Studies (2 papers), Injury Epidemiology and Prevention (2 papers), Escherichia coli research studies (2 papers), Viral gastroenteritis research and epidemiology (1 paper), SARS-CoV-2 and COVID-19 Research (1 paper), Salmonella and Campylobacter epidemiology (1 paper) and Vibrio bacteria research studies (1 paper). The work is most often cited by research in Endocrinology (136 citations), Molecular Medicine (104 citations), Infectious Diseases (151 citations), Parasitology (32 citations) and Emergency Medicine (42 citations). Peter T. Ender has collaborated with scholars based in United States. Frequent co-authors include Matthew J. Dolan, Brian Johnston, James R. Johnson, Connie Clabots, Steven J. Durning, Lannie J. Cation, David P. Dooley, Deepakraj Gajanana, Joseph C. Farmer and G. P. Melcher. Their work appears in journals such as Clinical Infectious Diseases, Open Forum Infectious Diseases, Journal of Emergency Medicine, The Pediatric Infectious Disease Journal and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.